BX Jun 2024 116.000 put
| Previous close | 0.5700 |
| Open | 0.6300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 116.00 |
| Expiry date | 2024-06-07 |
| Day's range | 0.5700 - 1.1600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
BloombergBlackstone Is Considering the Sale of Alinamin Pharmaceutical, Sources Say
(Bloomberg) -- Blackstone Inc. is considering a sale of Japanese consumer health-care firm Alinamin Pharmaceutical Co., which used to be owned by Takeda Pharmaceutical Co., according to people familiar with the situation.Most Read from BloombergKey Engines of US Consumer Spending Are Losing Steam All at OnceHomebuyers Are Starting to Revolt Over Steep Prices Across USMnuchin Chases Wall Street Glory With His War Chest of Foreign MoneyNvidia Unveils Next-Generation Rubin AI Platform for 2026GameS
Yahoo Finance UKTrending tickers: GameStop, Bitcoin, Saudi Aramco and Hipgnosis
The latest investor updates on stocks that are trending on Monday.
ReutersBlackstone set to sweeten Hipgnosis offer as part of revised bid, FT reports
The deal will need approval from 75% of voting shareholders of Hipgnosis, that owns the music rights of artists such as Shakira and Red Hot Chili Peppers, the newspaper said, citing people familiar with the matter. The offer would also require approval from the UK's Takeover Panel, and an announcement of the deal could come as early as Monday, the report said. Blackstone and Hipgnosis did not immediately respond to Reuters' requests for comment.
